Authors: Kassahun, K McIntosh, IS Shou, MG Walsh, DJ Rodeheffer, C Slaughter, DE Geer, LA Halpin, RA Agrawal, N Rodrigues, AD

Citation: K. Kassahun et al., Role of human liver cytochrome P4503A in the metabolism of etoricoxib, a novel cyclooxygenase-2 selective inhibitor, DRUG META D, 29(6), 2001, pp. 813-820

Authors: Baillie, TA Halpin, RA Matuszewski, BK Geer, LA Chavez-Eng, CM Dean, D Braun, M Doss, G Jones, A Marks, T Melillo, D Vyas, KP

Citation: Ta. Baillie et al., Mechanistic studies on the reversible metabolism of rofecoxib to 5-hydroxyrofecoxib in the rat: Evidence for transient ring opening of a substituted 2-furanone derivative using stable isotope-labeling techniques., DRUG META D, 29(12), 2001, pp. 1614-1628

Authors: Halpin, RA Geer, LA Zhang, KE Marks, TM Dean, DC Jones, AN Melillo, D Doss, G Vyas, KP

Citation: Ra. Halpin et al., The absorption, distribution, metabolism and excretion of rofecoxib, a potent and selective cyclooxygenase-2 inhibitor, in rats and dogs, DRUG META D, 28(10), 2000, pp. 1244-1254

Authors: Vyas, KP Halpin, RA Geer, LA Ellis, JD Liu, LD Cheng, HY Chavez-Eng, C Matuszewski, BK Varga, SL Guiblin, AR Rogers, JD

Citation: Kp. Vyas et al., Disposition and pharmacokinetics of the antimigraine drug, rizatriptan, inhumans, DRUG META D, 28(1), 2000, pp. 89-95